e7090
Showing 1 - 6 of 6
Breast Tumors Trial in Japan (E7090, Fulvestrant, Exemestane)
Recruiting
- Breast Neoplasms
- E7090
- +2 more
-
Nagoya, Aichi, Japan
- +10 more
Nov 11, 2022
Hepatic Impairment Trial in Yufu, Bunkyo-Ku, Minato-Ku (E7090)
Recruiting
- Hepatic Impairment
- E7090
-
Yufu, Oita, Japan
- +2 more
Jan 25, 2022
Advanced or Recurrent Solid Tumors, FGFR Gene Alterations Trial in Japan (E7090)
Recruiting
- Advanced or Recurrent Solid Tumors
- FGFR Gene Alterations
- E7090
-
Aoba-ku, Sendai, Miyagi, Japan
- +4 more
May 9, 2022
Healthy Participants Trial in Minato-ku (E7090, Rabeprazole 20 mg, Rifampin 600 mg)
Completed
- Healthy Participants
- E7090
- +2 more
-
Minato-ku, Tokoyo, JapanEisai trial site #1
Oct 29, 2021
Tumors Trial in Japan (E7090)
Completed
- Tumors
- E7090
-
Nagoya, Aichi, Japan
- +17 more
Sep 23, 2021
Cholangiocarcinoma Trial in China, Japan (E7090)
Active, not recruiting
- Cholangiocarcinoma
- E7090
-
Bengbu, Anhui, China
- +55 more
Jan 24, 2023